Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in refractory melanoma. Click to read.

ATLANTA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). The lawsuit ...

The Vibe-Coding Companies and Founders to Watch in 2025 From Anthropic to Replit, these are the key vibe-coding players to follow.

Donald Trump appeared delighted when he found out that Sydney Sweeney is reportedly a registered Republican amid continued uproar over her American Eagle jeans commercials. Various news outlets ...

Find the latest Replimune Group, Inc. (REPL) stock quote, history, news and other vital information to help you with your stock trading and investing.